Should medical journals carry drug advertising? Yes

BMJ

Volumn 335, Issue 7610, 2007, Pages 74-

  Smith, Richard ^a  

^a UnitedHealth Europe   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG INDUSTRY; DRUG MARKETING; MEDICAL LITERATURE; NOTE; PHYSICIAN; PRIORITY JOURNAL; PUBLICATION; ADVERTIZING; ARTICLE; ECONOMICS; LEGAL ASPECT;

ADVERTISING; DRUG INDUSTRY; PERIODICALS;

EID: 34447645983     PISSN: 09598138     EISSN: 14685833     Source Type: Journal    
DOI: 10.1136/bmj.39259.472998.AD     Document Type: Article

References (5)

1. Bombardier C, Laine L, Reicin A, Shapiro D, Burgos-Vargas R, Davis B, et al Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. N Engl J Med 2000; 343: 1520–1528.
2. Armstrong D. Bitter pill: how the New England Journal missed warning signs on Vioxx. Wall Street Journal 2006 May 15:A1.
3. Smith R. Lapses at the New England Journal of Medicine. J R Soc Med 2006; 99: 380–382.
4. Smith R. Medical journals are an extension of the marketing arm of pharmaceutical companies. PLoS Med 2005; 2: e138.
5. Smith R. Editorial misconduct, freedom and accountability: amateurs at work. In: The trouble with medical journals. London: RSM Press, 2006.